ArticleInternational journal of general medicine2022

Efficacy and Safety of Anlotinib Combined with PD-1 Blockades for Patients with Previously Treated Epithelial Ovarian Cancer: A Retrospective Study.

Xiao-Yuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.